Advanced Treatments & Technologies
First Successful Bedside CRRT at Peking Univers...
On April 9, Peking University Rehabilitation Hospital achieved a significant milestone by successfully performing its first bedside Continuous Renal Replacement Therapy (CRRT) in collaboration between the Intensive Care Rehabilitation Department...
First Successful Bedside CRRT at Peking Univers...
On April 9, Peking University Rehabilitation Hospital achieved a significant milestone by successfully performing its first bedside Continuous Renal Replacement Therapy (CRRT) in collaboration between the Intensive Care Rehabilitation Department...
First Successful Laser Interstitial Thermal The...
On August 11, Beijing Tiantan Puhua Hospital achieved a significant milestone by performing its first Magnetic Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT) to treat drug-resistant epilepsy. This minimally invasive procedure...
First Successful Laser Interstitial Thermal The...
On August 11, Beijing Tiantan Puhua Hospital achieved a significant milestone by performing its first Magnetic Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT) to treat drug-resistant epilepsy. This minimally invasive procedure...
Pioneering Non-Invasive Uterine Fibroid Treatme...
Beijing Tiantan Puhua Hospital has successfully performed its first Magnetic Resonance-guided Focused Ultrasound (MRgFUS) procedure for uterine fibroids, marking a significant advancement in non-invasive gynecological treatments. This innovative approach offers...
Pioneering Non-Invasive Uterine Fibroid Treatme...
Beijing Tiantan Puhua Hospital has successfully performed its first Magnetic Resonance-guided Focused Ultrasound (MRgFUS) procedure for uterine fibroids, marking a significant advancement in non-invasive gynecological treatments. This innovative approach offers...
Dr. Xian Zhang’s Latest Research on BCMA CAR-T ...
Dr. Xian Zhang's team at Ludaobei Hospital has made significant progress in the treatment of relapsed/refractory plasma cell myeloma (R/R MM). Their latest clinical study, published in Blood Advances, showcases...
Dr. Xian Zhang’s Latest Research on BCMA CAR-T ...
Dr. Xian Zhang's team at Ludaobei Hospital has made significant progress in the treatment of relapsed/refractory plasma cell myeloma (R/R MM). Their latest clinical study, published in Blood Advances, showcases...
Dr. Xingyu Cao: CD7 CAR-T Combined with Allogen...
Dr. Xingyu Cao’s groundbreaking research shows that CD7 CAR-T therapy combined with allo-HSCT significantly improves long-term survival in patients with relapsed/refractory T-ALL and T-LBL. The study, published in BJH, highlights...
Dr. Xingyu Cao: CD7 CAR-T Combined with Allogen...
Dr. Xingyu Cao’s groundbreaking research shows that CD7 CAR-T therapy combined with allo-HSCT significantly improves long-term survival in patients with relapsed/refractory T-ALL and T-LBL. The study, published in BJH, highlights...
Over 10,000 Hematopoietic Stem Cell Transplants...
On April 19, 2024, Ludaopei Hospital achieved a remarkable milestone by performing its 10,000th hematopoietic stem cell transplant. This achievement highlights the hospital's role as a leader in stem cell...
Over 10,000 Hematopoietic Stem Cell Transplants...
On April 19, 2024, Ludaopei Hospital achieved a remarkable milestone by performing its 10,000th hematopoietic stem cell transplant. This achievement highlights the hospital's role as a leader in stem cell...